Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-065618

EVP, Research & CSO sold 1,375 shares at $32.67 ($44,921)

  • EVP, Research & CSO acquired 1,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-11-16 Option exercise +1,375 $1.53 $2,104 109,075 D: show line 1 in the form
Virgin Herbert EVP, Research & CSO 2021-11-16 Sale −1,375 $32.67 $44,921 107,700 D: show line 2 in the form
Open-market sales · 1,375 sh · avg $32.67 · $44,921

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-11-16 Option exercise · Stock Option (Right to Buy) −1,375 245,630 D: show line 3 in the form
Loading xslF345X03/doc4.xml…